cAMPfield

cAMPfield Therapeutics

The company develops oral medicines for patients with inflammatory bowel disease, specifically focusing on a phosphodiesterase type 4 inhibitor called prifemilast.

Landos Biopharma

This company develops oral medicines for patients with autoimmune diseases, specifically targeting inflammatory bowel diseases such as ulcerative colitis and Crohn's disease.

First Wave

The company develops oral and topical therapies targeting disease-causing immune cells to treat patients suffering from gastrointestinal and chronic inflammatory diseases.

Ensho Therapeutics

This biopharmaceutical company develops oral small molecule therapies to treat patients suffering from inflammatory bowel disease, including ulcerative colitis and Crohn’s disease.

Promakhos Therapeutics

This company develops oral small molecule therapies to treat chronic inflammatory and autoimmune disorders for patients with conditions such as Crohn's disease.

Sorriso

This biopharmaceutical company develops oral antibody therapeutics to treat patients with immune-mediated diseases such as Crohn's disease and ulcerative colitis.

Boomerang Medical

This company develops bioelectric neuromodulation technology to treat autoimmune diseases, including inflammatory bowel disease, for patients with ulcerative colitis and Crohn's disease.

Caldera Therapeutics

This clinical-stage biotechnology company develops bispecific antibodies to treat patients with inflammatory bowel disease and other immune-mediated conditions.